Seaweed product to combat Blood Pressure Deccan Chronicle dated 29th May 2019

CMFRI, Library (2019) Seaweed product to combat Blood Pressure Deccan Chronicle dated 29th May 2019. Deccan Chronicle.

Preview

Text Deccan Chronicle_29-05-2019.pdf Download (174kB) | Preview

Abstract

In a major development, the Central Marine Fisheries Research Institute (CMFRI) here has come up with a nutraceutical product from seaweeds to combat hypertension. The product, CadalminTM Antihypertensive extract (CadalminTM AHe), is developed from medicinal seaweeds commonly present in the Indian coastal waters. Bioactive pharmacophore leads from seaweeds have been used to develop the product which can be administered orally to regulate hypertension that is one of the risk factors for strokes, heart attacks, heart failure, and arterial aneurysm, and is a leading cause of chronic kidney failure. This is sixth in the series of the nutraceutical products developed by CMFRI. The institute had developed and commercialised natural products for diseases such as diabetes, arthritis, cholesterol and hypothyroid.

Item Type:	Other
Uncontrolled Keywords:	Newspaper; News; CMFRI in Media
Subjects:	CMFRI News Clippings
Divisions:	Library and Documentation Centre
Depositing User:	Arun Surendran
Date Deposited:	27 Jul 2019 06:52
Last Modified:	13 Aug 2019 08:05
URI:	http://eprints.cmfri.org.in/id/eprint/13723

Actions (login required)

View Item